Chava Zibman, Ph.D.
Overview
Dr. Zibman brings biostatistical expertise to MCRA where she is responsible for clinical trial design, data analysis, and regulatory strategy as regards to the use of statistical methods in the evaluation of diagnostic devices in particular those relating to in vitro diagnostics, radiology, and digital health. She develops and reviews statistical analysis plans prior to clinical studies and is responsible for describing statistical methods and study results following study completion.